Aurobindo Pharma informs about company updates

11 Dec 2018 Evaluate

Aurobindo Pharma has informed has informed that its wholly owned subsidiary, Helix Healthcare B.V, Netherlands, has entered into an agreement with Shandong Luoxin Pharmaceutical Group Stock Co., Ltd, China (Luoxin) to establish a Joint Venture Company in China with manufacturing facilities to manufacture nebuliser inhaler and other products for China, US and EU markets. The disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Part A of Schedule III of the aforesaid regulations, is attached as Annexure A.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1183.35 -28.95 (-2.39%)
01-Feb-2026 14:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1613.00
Dr. Reddys Lab 1198.55
Cipla 1325.10
Zydus Lifesciences 887.00
Lupin 2127.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×